1 / 19

Countermeasure and Response Administration Overview and System Demonstration of V1.4

Countermeasure and Response Administration Overview and System Demonstration of V1.4. Webinar Presented to Public Health Project Areas and Partners Jeanne Tropper, MS, MPH CRA Development Team Division of Emergency Preparedness and Response National Center for Public Health Informatics.

ira
Télécharger la présentation

Countermeasure and Response Administration Overview and System Demonstration of V1.4

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Countermeasure and Response Administration Overview and System Demonstration of V1.4 Webinar Presented to Public Health Project Areas and Partners Jeanne Tropper, MS, MPH CRA Development Team Division of Emergency Preparedness and Response National Center for Public Health Informatics

  2. Purpose • Conduct overview of CDC’s Countermeasure and Response Administration (CRA) program and tools • Demonstrate V1.4 of Countermeasure Administration Tracking application • Answer questions

  3. What is CRA? • The program includes people, processes and tools to support the PHIN related activities for project areas and the CDC • Currently, CRA includes two major applications: • Administration Tracking – tracks “any countermeasure, any event” in detail or in aggregate given to patients • Inventory Tracking – monitors prioritized countermeasures within the supply chain; countermeasures include: pharmaceuticals and medical materials

  4. Administration Tracking • Capability to support mass tracking during an event • Genesis was pre-event vaccination system (PVS) for national smallpox vaccination campaign • System has been evolved to support any countermeasure, any event • Includes the ability to track both detail (person level) and aggregate counts of countermeasures

  5. Administration Tracking • V1.4 moved into production February 2007 (demonstration) • Improved flexibility to track any countermeasure for any event • Rapid data entry • Improved navigation

  6. Administration Tracking • The National Pandemic Influenza Plan requires monitoring of scarce pandemic influenza vaccine • States/ project areas will be required to track vaccine doses administered and collect and aggregate minimum data elements and transmit weekly to CDC • CRA was modified to support multiple ways of accepting the data: • Option 1: For states and project areas collecting data via an existing immunization information system (IIS) or other application, technical specifications were developed for three different data exchange formats: pipe delimited, XML file, HL 7 • Option 2: For states and project areas collecting data manually, an aggregate reporting screen was added to CDC’s CRA application to allow direct data entry via a web browser • Option 3: For states and project areas using CDC’s CRA application to collect patient level information, selected data elements will be automatically aggregated

  7. CRA Demonstration • Two Scenarios will be used to demonstrate CRA • Hepatitis A outbreak in a local restaurant • Pandemic influenza outbreak affecting multiple jurisdictions • Demonstration to include: • Set up tasks • Rapid data entry of patients receiving immune globulin (IG) prophylaxis • Long form data entry for hepatitis A vaccine • Isolation and quarantine record with antiviral prophylaxis • Aggregate reporting of vaccine doses administered

  8. CRA V1.4 Demonstration

  9. CRA Reports and Extracts • System-generated extracts • Datamart/Analysis extracts containing collected de-identified information available to CDC users • Jurisdiction extracts containing all data collected within a single jurisdiction available to Public Health Administrators (PHA) at each jurisdiction • User-generated reports • Public Health Reports generated by PHA; provide event and organization summaries and lists of patients • Clinic Reports generated by Data Entry Specialist (DES); provide clinic information including summaries, patient rosters, and activity reports

  10. Inventory Tracking • At any given moment, know the location and quantities of critical pharmaceuticals and medical supplies within the private sector • Be able to purchase and redirect quickly during an event • Envision initial use by CDC; in the future, state PH partners

  11. Inventory Tracking • Transitioning to new platform • Finalizing scope – initial focus on pandemic influenza anti-virals • Targeting next influenza season to have data streams from major manufacturers and distributors of antivirals

  12. When Would CRA be Used?

  13. CRA Outreach The CRA team has and continues to meet with public health partners as well as CDC scientists, epidemiologists and preparedness experts to solicit input on the CRA applications; the resulting list of recommendations has been used as the basis for future development efforts

  14. CRA Future Priorities

  15. Next Steps to Using CRA • Version 1.4 has been released into production as of February 2007 • Demonstration version is available for partner “try outs” • Consider using during an exercise • PHIN Help Desk first line of contact for accessing CRA • Telephone 1-800-532-9929: 8 AM to 8 PM EST •  Email:  Phintech@cdc.gov

  16. CRA Contacts • PHIN E-mail PHINTech@cdc.gov , Phone 800-532-9929 • Issuing digital certificates • Getting access to CRA demonstration site • Getting access to CRA Exchange, an interactive knowledge sharing and exchange web site (http://team.cdc.gov/) • Problem solving • CRA Help E-mail CRAHelp@cdc.gov • General aggregate reporting questions and inquiries

  17. Questions?

More Related